LSPRU
Larkspur Health Acquisition Corp Unit
Larkspur Health Acquisition Corp Unit historical holders
total: 1
Oaktree Capital Management Larkspur Health Acquisition Corp Unit transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2022 Q1
Howard Marks has been an institutional investor in Larkspur Health Acquisition Corp Unit (LSPRU) since 2021 Q4. According to 2026 Q2 report, Howard Marks doesn't hold any shares. The fund/company first acquired LSPRU in 2021 Q4, initially purchasing 700,000 shares. Since the initial investment, Oaktree Capital Management has made 1 more transaction in this position.
When did Howard Marks exit their LSPRU position?
Howard Marks no longer holds Larkspur Health Acquisition Corp Unit (LSPRU). They sold off their entire position in 2022 Q1, closing out an investment that began in 2021 Q4.
When did Howard Marks first invest in LSPRU?
Howard Marks first invested in Larkspur Health Acquisition Corp Unit (LSPRU) in 2021 Q4 at the reported quarter-end price of $10.02 per share, acquiring 700,000 shares in their initial purchase.
What is Howard Marks's average cost basis for LSPRU?
Based on historical transaction data, Howard Marks's estimated cost basis for Larkspur Health Acquisition Corp Unit (LSPRU) is approximately $10.02 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $10.02
- Weighted AVG sell price:
- $10.02
LSPRU transactions history by Oaktree Capital Management
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q1
|
0.00%
|
0
|
$10.02
|
|
-100% (-700,000)
|
-0.08%
|
|
2021 Q4
|
0.08%
|
700,000
|
$10.02
|
$7,014,000
|
new
|
+0.08%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.